Measuring asthma control: A comparison of three classification systems

European Respiratory Journal

Volumn 36, Issue 2, 2010, Pages 269-276

  O'Byrne, P M ^a,b   Reddel, H K ^c   Eriksson, G ^d,e   Ostlund O ^d   Peterson, S ^d   Sears, M R ^c   Jenkins, C ^c   Humbert, M ^f   Buhl, R ^g   Harrison, T W ^h   Quirce, S ⁱ   Bateman, E D ^j  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c WOOLCOCK INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d ASTRAZENECA R AND D   (Sweden)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

^f UNIVERSITÉ PARIS SACLAY   (France)

^g UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^h UNIVERSITY OF NOTTINGHAM   (United Kingdom)

ⁱ HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^j UNIVERSITY OF CAPE TOWN   (South Africa)

more..

Author keywords

Asthma control; Asthma control questionnaire; Gaining optimal asthma control; Global initiative for asthma

Indexed keywords

BUDESONIDE PLUS FORMOTEROL; FLUTICASONE PROPIONATE PLUS SALMETEROL; FORMOTEROL; TERBUTALINE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; ASTHMA CONTROL QUESTIONNAIRE; CHILD; CLINICAL ASSESSMENT; DISEASE CONTROL; FEMALE; GAINING OPTIMAL ASTHMA CONTROL; GLOBAL INITIATIVE FOR ASTHMA; HUMAN; KAPPA STATISTICS; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PRIORITY JOURNAL; QUESTIONNAIRE; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; ASTHMA; BUDESONIDE; CHILD; DOUBLE-BLIND METHOD; ETHANOLAMINES; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY MEDICINE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 77955592391     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00124009     Document Type: Article

References (21)

1. National Asthma Education and Prevention Program, Expert Panel Report 3 (EPR-3): Guidelines for the diagnosis and management of asthma - Summary Report 2007. J Allergy Clin Immunol 2007; 120: Suppl. 5, S94-S138.
2. Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31: 143-178.
3. British Thoracic Society, Scottish Intercollegiate Guidelines Network. British Guideline on the Management of Asthma: A National Clinical Guideline. June 2009. www.sign.ac.uk/pdf/sign101.pdf
4. Bateman ED, Boushey HA, Bousquet J, et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med 2004; 170: 836-844. (Pubitemid 39346477)
5. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. Updated 2008. www.ginasthma.com/Guidelineitem.asp??l1=2&l2= 1&intId=60
6. Juniper EF, O'Byrne PM, Guyatt GH, et al. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999; 14: 902-907. (Pubitemid 29519356)
7. Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 2004; 113: 59-65. (Pubitemid 38096162)
8. Skinner EA, Diette GB, Algatt-Bergstrom PJ, et al. The Asthma Therapy Assessment Questionnaire (ATAQ) for children and adolescents. Dis Manag 2004; 7: 305-313.
9. Juniper EF, Svensson K, Mörk AC, et al. Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respir Med 2005; 99: 553-558. (Pubitemid 40468501)
10. Svensson K, Mork AC, Juniper EF. ACQ - is five out of seven items acceptable in large clinical studies? Qual Life Res 2003; 12: 771.
11. Juniper EF, O'Byrne PM, Roberts JN. Measuring asthma control in group studies: do we need airway calibre and rescue β2-agonist use? Respir Med 2001; 95: 319-323.
12. Juniper EF, Bousquet J, Abetz L, et al. Identifying "well- controlled" and "not well-controlled" asthma using the Asthma Control Questionnaire. Respir Med 2006; 100: 616-621.
13. Thomas M, Kay S, Pike J, et al. The Asthma Control Test (ACT) as a predictor of GINA guideline-defined asthma control: analysis of a multinational cross-sectional survey. Prim Care Respir J 2009; 18: 41-49.
14. Khalili B, Boggs PB, Shi R, et al. Discrepancy between clinical asthma control assessment tools and fractional exhaled nitric oxide. Ann Allergy Asthma Immunol 2008; 101: 124-129.
15. Bousquet J, Boulet LP, Peters MJ, et al. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/ fluticasone. Respir Med 2007; 101: 2437-2446. (Pubitemid 350010579)
16. Kuna P, Peters MJ, Manjra AI, et al. Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations. Int J Clin Pract 2007; 61: 725-736. (Pubitemid 46587876)
17. Rabe KF, Atienza T, Magyar P, et al. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. Lancet 2006; 368: 744-753. (Pubitemid 44279053)
18. Cohen J, ed. Statistical Power Analysis for the Behavioural Sciences. 2nd Edn. Hillsdale, Lawrence Erlbaum Associates, 1988.
19. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-174.
20. Wallenstein GV, Carranza-Rosenzweig J, Kosinski M, et al. A psychometric comparison of three patient-based measures of asthma control. Curr Med Res Opin 2007; 23: 369-377. (Pubitemid 46333385)
21. Bateman ED, Reddel HK, Ericksson G, et al. Overall asthma control: the relationship between current control and future risk. J Allergy Clin Immunol 2010; 125: 600-608.